login
login
Image header Agence Europe
Europe Daily Bulletin No. 12401
Contents Publication in full By article 19 / 30
ECONOMY - FINANCE - BUSINESS / Competition

Commission clears acquisition of Allergan by AbbVie, subject to conditions

The European Commission cleared on Friday 10 January the proposed acquisition of Allergan Plc. (Republic of Ireland) by AbbVie Inc. (United States) for $63 billion (56.75 billion euros). Approval is conditional upon the divestment by Allergan of a product for the treatment of inflammatory bowel diseases.

Margrethe Vestager, Executive Vice-President of the Commission, explained that the Commission’s decision ensures that the merger “will not disrupt the development of a promising...

Contents

EXTERNAL ACTION
INSTITUTIONAL
SOCIAL AFFAIRS
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
NEWS BRIEFS
The B-word: Agence Europe’s newsletter on Brexit
CALENDAR
CALENDAR EXTRA